Answer
Patients should be tested for hepatitis B virus (HBV) infection before starting asciminib hydrochloride; HBV carriers requiring treatment should be closely monitored for signs and symptoms of active infection throughout therapy and for several months after treatment ends.
Sources for this answer
- Scemblix 20 mg and 40 mg film-coated tabletsNovartis Pharmaceuticals UK Ltd · emc · SmPC §4.4 Special warnings and precautions for use · Version 9Document updated
Sources checked